
Merieux Equity buys Plantex
Merieux Equity Partners has acquired a majority stake in Plantex, a French producer of botanical extracts.
The deal was supported with a senior debt package provided by Societe Generale and a mezzanine facility deployed by Cerea Partners.
The GP invested in the company via Merieux Participations 3, which was launched in July 2018 and closed on €377m in January 2020, surpassing its initial €350m target. The fund backs French companies primarily operating across the food and healthcare industries.
The GP intends to support Plantex in boosting its growth both organically and via a buy-and-build strategy, while strengthening its market position and further bolstering its international expansion.
Company
Established in 1990 and based in Saint-Michel-sur-Orge, near Paris, Plantex specialises in producing plant extracts for the food, cosmetics, nutraceutical and animal nutrition industries. Its products comprise dry and liquid extracts from 250 plant varieties and include organic and tailor-made extracts.
Plantex employs 75 staff and generates annual revenues of around €30m.
People
Merieux Equity Partners – Thierry Chignon (managing partner).
Plantex – Aicha Debaisieux (president).
Advisers
Equity – 8Advisory (financial due diligence); Advancy (commercial due diligence); Duteil Avocats (legal); CMS (tax); Lincoln International (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater